Linking pages
- Drug made famous by Shkreli’s 5,000% price hike is still $750 a pill | Ars Technica https://arstechnica.com/tech-policy/2018/05/drug-made-famous-by-shkrelis-5000-price-hike-is-still-750-a-pill/ 341 comments
- Sorry Elon Musk, there’s no clear evidence Autopilot saves lives | Ars Technica https://arstechnica.com/cars/2018/05/sorry-elon-musk-theres-no-clear-evidence-autopilot-saves-lives/ 68 comments
Linked pages
- Drug made famous by Shkreli’s 5,000% price hike is still $750 a pill | Ars Technica https://arstechnica.com/tech-policy/2018/05/drug-made-famous-by-shkrelis-5000-price-hike-is-still-750-a-pill/ 341 comments
- Sorry Elon Musk, there’s no clear evidence Autopilot saves lives | Ars Technica https://arstechnica.com/cars/2018/05/sorry-elon-musk-theres-no-clear-evidence-autopilot-saves-lives/ 68 comments
- YouTube expands firearms restrictions, more gun videos to be banned | Ars Technica https://arstechnica.com/information-technology/2018/03/youtube-to-crack-down-harder-on-videos-about-building-buying-firearms/ 0 comments
- YouTube raises subscriber, view threshold for Partner Program monetization | Ars Technica https://arstechnica.com/gadgets/2018/01/youtube-raises-subscriber-view-threshold-for-partner-program-monetization/ 0 comments
- After Logan Paul incident, Google Preferred YouTube videos will face further vetting | Ars Technica https://arstechnica.com/gadgets/2018/01/google-to-vet-youtube-videos-that-are-part-of-its-top-tier-ad-program/ 0 comments
Related searches:
Search whole site: site:arstechnica.com
Search title: Over a 5th of the world’s population is logging in to YouTube—despite scandals | Ars Technica
See how to search.